The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SBRT with ipilimumab and nivolumab to metastatic MSS colorectal and pancreatic cancer: A pooled analysis of four prospective phase II trials.
 
Hannah Johnson Roberts
No Relationships to Disclose
 
Jessica Seidenberg
No Relationships to Disclose
 
Beow Y. Yeap
Stock and Other Ownership Interests - SISCAPA Assay Technologies (I)
Consulting or Advisory Role - Guardant Health (I)
 
Julie L. Koenig
No Relationships to Disclose
 
Aparna Raj Parikh
Consulting or Advisory Role - Abbvie; Bayer; Biofidelity; Checkmate Pharmaceuticals; CVS; Delcath Systems; Foundation Medicine; Guardant Health; Illumina; Lilly; SAGA Diagnostics; Scarce; Seagen; Taiho Oncology; Takeda; UpToDate; Value Analytics Labs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
Travel, Accommodations, Expenses - Karkinos Healthcare; Karkinos Healthcare
Other Relationship - C2i genomics; Parithera; Xact Robotics
 
Jeffrey William Clark
Employment - UpToDate
Research Funding - Pfizer (Inst)
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; Bioimpact Capital; Cullinan Oncology; Exact Sciences; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Innocrin Pharma; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics
 
Jill N. Allen
No Relationships to Disclose
 
Colin D. Weekes
Honoraria - Bayer; Celgene; Lilly
Consulting or Advisory Role - Celgene; Ipsen; Merrimack
Research Funding - Actuate Therapeutics; AstraZeneca; Celgene; Dicephera Pharmaceuticals, Inc.; Genentech/Roche; Novartis
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I)
 
Priyadarshini Pathak
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
Leilana Ly
No Relationships to Disclose
 
Theodore S. Hong
Stock and Other Ownership Interests - PanTher Therapeutics
Consulting or Advisory Role - Boston Scientific; Merck; NextCure; Novocure; Syndax; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); IntraOp (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Jennifer Yon-Li Wo
Honoraria - PER
Research Funding - Genentech/Roche (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Lynx Group